Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 21, 2017 (9 years ago)

Medline General Purpose Tray

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Medline General Purpose Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060

Recalling firm
Medline Industries Inc
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0283-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Medline Industries Inc

All 2017 recalls
Class II · Moderate risk

Hand Sanitizer Foam

Defective Container: Customer complaints for leaking bottles and dispensing issues.

Terminated Packaging defect Medline Industries Inc NDC 53329-970-12 D-0287-2022
Class III · Low risk

Readyprep Chg

Superpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate.

Terminated Wrong potency / content Medline Industries Inc D-0624-2021
Class II · Moderate risk

PVP Scrub Solution

Subpotent Drug: product not meeting the iodine assay level requirements through the labeled expiry.

Terminated Wrong potency / content Medline Industries Inc NDC 53329-938-04 D-0546-2018

Other wrong potency / content recalls from 2017

All wrong potency / content recalls
Class II · Moderate risk

Viokace (pancrelipase)

Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.

Terminated Wrong potency / content Allergan NDC 58914-117-10 D-0154-2018